Jump to main content
Jump to site search

Issue 75, 2017
Previous Article Next Article

An in-tether chiral center modulates the proapoptotic activity of the KLA peptide

Author affiliations

Abstract

The helical peptide KLA (KLAKLAKKLAKLAK) is a well-known inducer of cellular apoptosis, acting to disrupt the mitochondrial membrane. However, its weak cellular uptake impedes development of any further applications. Here, we have utilized a novel in-tether chiral center induced helicity strategy (CIH) to develop a potent apoptosis inducer based on this KLA sequence. Notably, for the two resulting epimers of the CIH-KLA peptide, the CIH-KLA-(R) epimer exhibited superior cellular uptakes and special mitochondrial targeting when compared with its S counterpart. This work provides a promising and versatile method to modify the KLA peptide and a proof-of-concept application for the CIH strategy in modifying bioactive peptides.

Graphical abstract: An in-tether chiral center modulates the proapoptotic activity of the KLA peptide

Back to tab navigation

Supplementary files

Publication details

The article was received on 26 Jun 2017, accepted on 30 Aug 2017 and first published on 30 Aug 2017


Article type: Communication
DOI: 10.1039/C7CC04923D
Citation: Chem. Commun., 2017,53, 10452-10455
  •   Request permissions

    An in-tether chiral center modulates the proapoptotic activity of the KLA peptide

    J. Li, K. Hu, H. Chen, Y. Wu, L. Chen, F. Yin, Y. Tian and Z. Li, Chem. Commun., 2017, 53, 10452
    DOI: 10.1039/C7CC04923D

Search articles by author

Spotlight

Advertisements